Claudia Cava
Claudia Cava
IBFM-CNR
Email verificata su ibfm.cnr.it
Titolo
Citata da
Citata da
Anno
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ...
Nucleic acids research 44 (8), e71-e71, 2016
11322016
MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer
G Bertoli, C Cava, I Castiglioni
Theranostics 5 (10), 1122, 2015
5832015
MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer
G Bertoli, C Cava, I Castiglioni
International journal of molecular sciences 17 (3), 421, 2016
1262016
In silico discovery of candidate drugs against Covid-19
C Cava, G Bertoli, I Castiglioni
Viruses 12 (4), 404, 2020
932020
Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition
C Cava, G Bertoli, M Ripamonti, G Mauri, I Zoppis, PAD Rosa, MC Gilardi, ...
PloS one 9 (5), e97681, 2014
552014
Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression
VB Stefania Tommasi, Paolo Pannarale, Mirko Abbrescia, Claudia Cava
Lecture Notes in Computer Science (including subseries Lecture Notes in …, 2011
51*2011
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
L Cantini, G Bertoli, C Cava, T Dubois, A Zinovyev, M Caselle, ...
Nucleic acids research 47 (5), 2205-2215, 2019
452019
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
C Cava, G Bertoli, I Castiglioni
BMC systems biology 9 (1), 1-36, 2015
452015
SpidermiR: an R/bioconductor package for integrative analysis with miRNA data
C Cava, A Colaprico, G Bertoli, A Graudenzi, TC Silva, C Olsen, ...
International journal of molecular sciences 18 (2), 274, 2017
402017
Integrative analysis with Monte Carlo cross-validation reveals miRNAs regulating pathways cross-talk in aggressive breast cancer
A Colaprico, C Cava, G Bertoli, G Bontempi, I Castiglioni
BioMed research international 2015, 2015
372015
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
C Cava, G Bertoli, A Colaprico, C Olsen, G Bontempi, I Castiglioni
BMC genomics 19 (1), 1-16, 2018
272018
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
G Bertoli, C Cava, C Diceglie, C Martelli, G Rizzo, F Piccotti, L Ottobrini, ...
Breast cancer research and treatment 161 (3), 605-616, 2017
272017
The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer
G Bertoli, C Cava, I Castiglioni
Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245 …, 2016
272016
Potential role of miRNAs as theranostic biomarkers of epilepsy
C Cava, I Manna, A Gambardella, G Bertoli, I Castiglioni
Molecular Therapy-Nucleic Acids 13, 275-290, 2018
222018
How interacting pathways are regulated by miRNAs in breast cancer subtypes
C Cava, A Colaprico, G Bertoli, G Bontempi, G Mauri, I Castiglioni
BMC bioinformatics 17 (12), 111-133, 2016
212016
Radiation-induced gene expression changes in high and low grade breast cancer cell types
V Bravatà, C Cava, L Minafra, FP Cammarata, G Russo, MC Gilardi, ...
International journal of molecular sciences 19 (4), 1084, 2018
202018
Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference
C Cava, I Zoppis, M Gariboldi, I Castiglioni, G Mauri, M Antoniotti
Journal of clinical bioinformatics 4 (1), 1-15, 2014
202014
MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015; 5: 1122–43
G Bertoli, C Cava, I Castiglioni
20
Interpreting pathways to discover cancer driver genes with Moonlight
A Colaprico, C Olsen, MH Bailey, GJ Odom, T Terkelsen, TC Silva, ...
Nature communications 11 (1), 1-17, 2020
192020
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
C Cava, G Bertoli, I Castiglioni
Journal of translational medicine 16 (1), 1-17, 2018
172018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20